Levitt asks Templeton to reconsider vote
Levitt asks Templeton to reconsider vote
Jerusalem: Taro Pharmaceuticals Industries Ltd’s chairman Barrie Levitt asked shareholder Templeton Asset Management Ltd in a letter on Sunday to reconsider a planned vote against the board at the annual meeting scheduled for 31 December.
Levitt’s letter was emailed to Bloomberg News.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!